December 29th, 2025 by WCBC Radio
Skin and prostate cancer therapies are undergoing research by Medicus Pharma. Talking with WCBC, Raza Bokhari, Executive Director of Medicus, said researchers have developed new hormone deprivation therapy for advanced prostate cancers which could also be cardio protective. Bokhari says an oral form of the therapy is already available and an injectable is on the way…
“We are advancing an injectable which is a next generation hormone antagonist and we have treated so 40 patients in clinical trials, and we have some very positive results.”


.jpg)











